INS and Alzheimer disease: On the other hand, stimulating glucose metabolism in AD patients through the administration of insulin or GLP-1, significantly improves the cognitive function, supporting the close relationship between the deregulation of cerebral glucose metabolism and the cognitive failures described in AD (84, 85).